Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-009773

Director acquired 4,294 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Velleca Mark A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-16 Grant or award : show line 1 in the form +4,294 $2.62 $11,250 12,733 D
Loading xslF345X03/form4-09192022_020914.xml…